190

Allergy&Clinical immunology
Sub Categories on Allergy&Clinical immunology
Latest Articles
Reactivation of dormant regulatory T cells alleviates asthma symptoms in mice

Reactivation of dormant regulatory T cells alleviates asthma symptoms in mice

byRockefeller University PressTreatment with KQS-1 (right) significantly reduces the amount of inflammation observed in tissue samples taken from asthmatic mice in comparison to untreated controls (le

Reactivation of dormant regulatory T cells alleviates asthma symptoms in mice

byRockefeller University PressTreatment with KQS-1 (right) significantly reduces the amount of inflammation observed in tissue samples taken from asthmatic mice in comparison to untreated controls (le
No link found between childhood atopic dermatitis and markers of cardiovascular risk

No link found between childhood atopic dermatitis and markers of cardiovascular risk

by Lori SolomonAtopic dermatitis (AD) during childhood is not associated with increases in markers of cardiovascular risk, according to a study published online March 24 inJAMA Network Open.Morgan Ye,

No link found between childhood atopic dermatitis and markers of cardiovascular risk

by Lori SolomonAtopic dermatitis (AD) during childhood is not associated with increases in markers of cardiovascular risk, according to a study published online March 24 inJAMA Network Open.Morgan Ye,
Algae-derived sugars show anti-inflammatory effects and support skin repair

Algae-derived sugars show anti-inflammatory effects and support skin repair

byEstonian Research CouncilAmal D. Premarathna. Credit: Amal D. PremarathnaChronic wounds affect approximately 2% of the population in developed countries. Existing treatments are expensive and may ca

Algae-derived sugars show anti-inflammatory effects and support skin repair

byEstonian Research CouncilAmal D. Premarathna. Credit: Amal D. PremarathnaChronic wounds affect approximately 2% of the population in developed countries. Existing treatments are expensive and may ca
Macrophages in 'marathon mode' may drive skin granulomas, pointing to new therapies

Macrophages in 'marathon mode' may drive skin granulomas, pointing to new therapies

by Uta von der Gönna, Jena UniversityCredit:Science Advances(2026). DOI: 10.1126/sciadv.aea0773An international research team has succeeded in elucidating key immunological and biochemical mechanisms

Macrophages in 'marathon mode' may drive skin granulomas, pointing to new therapies

by Uta von der Gönna, Jena UniversityCredit:Science Advances(2026). DOI: 10.1126/sciadv.aea0773An international research team has succeeded in elucidating key immunological and biochemical mechanisms
Orthodontics researchers evaluate microplastics' effect on immune system

Orthodontics researchers evaluate microplastics' effect on immune system

by Laurie Kaiser,University at BuffaloCharacterization of orthodontic-derived plastic particles. Credit:Progress in Orthodontics(2026). DOI: 10.1186/s40510-026-00608-3In a new study, orthodontics rese

Orthodontics researchers evaluate microplastics' effect on immune system

by Laurie Kaiser,University at BuffaloCharacterization of orthodontic-derived plastic particles. Credit:Progress in Orthodontics(2026). DOI: 10.1186/s40510-026-00608-3In a new study, orthodontics rese
How T cells amplify signals: New study reveals key molecular switch

How T cells amplify signals: New study reveals key molecular switch

byDelthia Ricks, Medical XpressScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDSignaling is fundamental to how cells

How T cells amplify signals: New study reveals key molecular switch

byDelthia Ricks, Medical XpressScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDSignaling is fundamental to how cells
FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder

FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder

byUniversity of California, Los AngelesUCLA's Dr. Donald Kohn with Marley Gaskins and her mother, Tamara Hogue. Marley was the first patient to enroll in the LAD-l clinical trial in 2019. Credit:

FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder

byUniversity of California, Los AngelesUCLA's Dr. Donald Kohn with Marley Gaskins and her mother, Tamara Hogue. Marley was the first patient to enroll in the LAD-l clinical trial in 2019. Credit:
How cells fight infection from the inside: Newly identified ADX pathway may broaden understanding of immunity

How cells fight infection from the inside: Newly identified ADX pathway may broaden understanding of immunity

byCell PressSuper-resolution image of an LC3-positive autophagosome engulfing a TRIM21- and antibody-coated adenovirus. Credit: Claudia Puri, Matthew J. Gratian, Anna Albecka, and Tyler Rhinesmith.Whe

How cells fight infection from the inside: Newly identified ADX pathway may broaden understanding of immunity

byCell PressSuper-resolution image of an LC3-positive autophagosome engulfing a TRIM21- and antibody-coated adenovirus. Credit: Claudia Puri, Matthew J. Gratian, Anna Albecka, and Tyler Rhinesmith.Whe
Early immunotherapy aids in treating potentially fatal fungal pneumonias in preclinical models

Early immunotherapy aids in treating potentially fatal fungal pneumonias in preclinical models

byUniversity of Texas MD Anderson Cancer CenterHematoxylin & eosin-stained lung tissue sections according to the treatment arm, showing an absence of lymphocytic infiltrates, even in mice that rec

Early immunotherapy aids in treating potentially fatal fungal pneumonias in preclinical models

byUniversity of Texas MD Anderson Cancer CenterHematoxylin & eosin-stained lung tissue sections according to the treatment arm, showing an absence of lymphocytic infiltrates, even in mice that rec
New drug cuts relapse risk by half in rare immune disorder trial

New drug cuts relapse risk by half in rare immune disorder trial

by Sarah Williams,Stanford UniversityIn IgG4-related disease, B cells (above) attack the body's own tissue. A study led by Stanford Medicine has found that a drug reduces the chance of relapse. Cr

New drug cuts relapse risk by half in rare immune disorder trial

by Sarah Williams,Stanford UniversityIn IgG4-related disease, B cells (above) attack the body's own tissue. A study led by Stanford Medicine has found that a drug reduces the chance of relapse. Cr